Fibrinogen: a possible link between social class and coronary heart disease. 1985

H L Markowe, and M G Marmot, and M J Shipley, and C J Bulpitt, and T W Meade, and Y Stirling, and M V Vickers, and A Semmence

Mortality from coronary heart disease in civil servants in the lowest grade of employment has been found to be about three times that of men in the highest grade of employment. As part of an investigation of this finding several haemostatic variables were measured in a sample of 29 men in lower grades of employment and 45 men in higher grades. There was a significant difference in plasma fibrinogen concentrations between men in lower grades of employment and those in higher grades (mean 3.39 g/l v 2.95 g/l, respectively; p less than 0.01) but not in other haemostatic variables. Multiple regression analyses showed significant independent associations of fibrinogen concentration with smoking (p less than 0.05) and grade of employment (p less than 0.05). The size of the observed difference between the grades of employment was similar to that between those dying of coronary heart disease or surviving during longitudinal study; it may therefore be an important part of the mechanism underlying social class differences in coronary heart disease. The statistical relation between fibrinogen concentrations and other characteristics that may be concerned in the aetiology of coronary heart disease was examined. A summary measure of job stress was significantly related to fibrinogen concentration (p less than 0.01) and made a substantial contribution to explaining the differences between grades of employment. Behaviour type and a score of physical activity were not significantly related to fibrinogen concentration.

UI MeSH Term Description Entries
D008131 London The capital of the United Kingdom. It is located in England.
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D003327 Coronary Disease An imbalance between myocardial functional requirements and the capacity of the CORONARY VESSELS to supply sufficient blood flow. It is a form of MYOCARDIAL ISCHEMIA (insufficient blood supply to the heart muscle) caused by a decreased capacity of the coronary vessels. Coronary Heart Disease,Coronary Diseases,Coronary Heart Diseases,Disease, Coronary,Disease, Coronary Heart,Diseases, Coronary,Diseases, Coronary Heart,Heart Disease, Coronary,Heart Diseases, Coronary
D004651 Employment The state of being engaged in an activity or service for wages or salary. Employment Termination,Employment Status,Labor Force,Occupational Status,Status, Occupational,Underemployment,Labor Forces,Status, Employment,Termination, Employment
D005260 Female Females
D005340 Fibrinogen Plasma glycoprotein clotted by thrombin, composed of a dimer of three non-identical pairs of polypeptide chains (alpha, beta, gamma) held together by disulfide bonds. Fibrinogen clotting is a sol-gel change involving complex molecular arrangements: whereas fibrinogen is cleaved by thrombin to form polypeptides A and B, the proteolytic action of other enzymes yields different fibrinogen degradation products. Coagulation Factor I,Factor I,Blood Coagulation Factor I,gamma-Fibrinogen,Factor I, Coagulation,gamma Fibrinogen
D006487 Hemostasis The process which spontaneously arrests the flow of BLOOD from vessels carrying blood under pressure. It is accomplished by contraction of the vessels, adhesion and aggregation of formed blood elements (eg. ERYTHROCYTE AGGREGATION), and the process of BLOOD COAGULATION. Hemostases
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults

Related Publications

H L Markowe, and M G Marmot, and M J Shipley, and C J Bulpitt, and T W Meade, and Y Stirling, and M V Vickers, and A Semmence
December 1985, British medical journal (Clinical research ed.),
H L Markowe, and M G Marmot, and M J Shipley, and C J Bulpitt, and T W Meade, and Y Stirling, and M V Vickers, and A Semmence
June 1994, Lancet (London, England),
H L Markowe, and M G Marmot, and M J Shipley, and C J Bulpitt, and T W Meade, and Y Stirling, and M V Vickers, and A Semmence
January 2008, Evidence-based dentistry,
H L Markowe, and M G Marmot, and M J Shipley, and C J Bulpitt, and T W Meade, and Y Stirling, and M V Vickers, and A Semmence
January 2008, European journal of epidemiology,
H L Markowe, and M G Marmot, and M J Shipley, and C J Bulpitt, and T W Meade, and Y Stirling, and M V Vickers, and A Semmence
October 2002, South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde,
H L Markowe, and M G Marmot, and M J Shipley, and C J Bulpitt, and T W Meade, and Y Stirling, and M V Vickers, and A Semmence
January 1981, British heart journal,
H L Markowe, and M G Marmot, and M J Shipley, and C J Bulpitt, and T W Meade, and Y Stirling, and M V Vickers, and A Semmence
August 1993, Circulation,
H L Markowe, and M G Marmot, and M J Shipley, and C J Bulpitt, and T W Meade, and Y Stirling, and M V Vickers, and A Semmence
February 1996, Anesthesiology,
H L Markowe, and M G Marmot, and M J Shipley, and C J Bulpitt, and T W Meade, and Y Stirling, and M V Vickers, and A Semmence
April 1999, Arteriosclerosis, thrombosis, and vascular biology,
H L Markowe, and M G Marmot, and M J Shipley, and C J Bulpitt, and T W Meade, and Y Stirling, and M V Vickers, and A Semmence
January 2016, Innate immunity,
Copied contents to your clipboard!